Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Checkpoint Therapeutics Inc shares valued at $2,330,386 were sold by Oliviero James F III on Dec 18 ’24. At $3.87 per share, Oliviero James F III sold 602,167 shares. The insider’s holdings dropped to 3,414,813 shares worth approximately $12.43 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Oliviero James F III sold 220,230 shares, netting a total of over 744,377 in proceeds. Following the sale of shares at $3.38 each, the insider now holds 3,194,583 shares.
Before that, GRAY WILLIAM GARRETT had sold 268,432 shares from its account. In a trade valued at $1,076,412, the Chief Financial Officer traded Checkpoint Therapeutics Inc shares for $4.01 each. Upon closing the transaction, the insider’s holdings decreased to 268,432 shares, worth approximately $3.76 million.
Analysts at B. Riley Securities started covering the stock with ‘”a Buy”‘ outlook in a report released in early June. As of January 20, 2021, Cantor Fitzgerald has initiated its “an Overweight” rating for CKPT. Earlier on May 29, 2019, Lake Street initiated its rating. Their recommendation was “a Buy” for CKPT stock.
Analyzing CKPT Stock Performance
During the last five days, there has been a drop of approximately -4.17%. Over the course of the year, Checkpoint Therapeutics Inc shares have jumped approximately 55.46%. Shares of the company reached a 52-week high of $4.50 on 12/02/24 and a 52-week low of $1.38 on 05/01/24. A 50-day SMA is recorded $3.60, while a 200-day SMA reached $2.44. Nevertheless, trading volume fell to 0.5 million shares from 1.35 million shares the previous day.
Support And Resistance Levels for Checkpoint Therapeutics Inc (CKPT)
According to the 24-hour chart, there is a support level at 3.48, which, if violated, would cause prices to drop to 3.33. In the upper region, resistance lies at 3.72. The next price resistance is at 3.81. RSI (Relative Strength Index) is 46.98 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.12, which suggests the price will decrease in the coming days. Percent R is at 54.79%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
Which companies own the most shares of Checkpoint Therapeutics Inc (CKPT)?
On December 08, 2017, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $11.
